Public Citizen Calls for Ban on Leflunomide

NEW YORK (MedscapeWire) Apr 05 — The rheumatoid arthritis drug leflunomide (Arava) should be banned, a consumer watchdog group says.
Leflunomide has been linked to 22 deaths in its first 3 years of approval, according to US Food and Drug Administration (FDA) data obtained by the watchdog group Public Citizen. Twelve of the deaths appear to be directly due to liver damage from the drug. A total of 130 severe liver reactions have been reported, including 56 hospitalizations.

לכתבה המלאה

0 תגובות

השאירו תגובה

רוצה להצטרף לדיון?
תרגישו חופשי לתרום!

כתיבת תגובה

מידע נוסף לעיונך

כתבות בנושאים דומים